Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell endometrial cancer

Southern Medical Journal

Volumn 101, Issue 12, 2008, Pages 1266-1268

  Richey, Daniel S ^a   Welch, Brian J ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hypercalcemia; Hyperparathyroidism; Parathyroid hormone related peptide

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ATORVASTATIN; CALCIUM; CLONIDINE; CLOPIDOGREL; DOCETAXEL; MULTIVITAMIN; PAMIDRONIC ACID; PARATHYROID HORMONE RELATED PROTEIN;

AGED; ARTICLE; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; CAUCASIAN; CLEAR CELL CARCINOMA; ENDOMETRIUM CANCER; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; PARATHYROID ADENOMA; PRIMARY HYPERPARATHYROIDISM; RECURRENT CANCER; STROKE; ADENOCARCINOMA; ADENOMA; BLOOD; DISEASE COURSE; ENDOMETRIUM TUMOR; MULTIPLE CANCER; PARATHYROID TUMOR; PARATHYROIDECTOMY; POSTOPERATIVE COMPLICATION;

ADENOCARCINOMA, CLEAR CELL; ADENOMA; AGED; CALCIUM; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; NEOPLASMS, MULTIPLE PRIMARY; PARATHYROID HORMONE-RELATED PROTEIN; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; POSTOPERATIVE COMPLICATIONS;

EID: 58149331410     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318181d59d     Document Type: Article

References (13)

1. Walls J, Ratcliffe WA, Howell A, et al. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcemia in two hospital populations. Clin Endocrinol (Oxf) 1994;41:407-413.
2. Gallacher SJ, Fraser WD, Farquharson MA, et al. Coincidental occurrence of primary hyperparathyroidism and cancer-associated hypercalcemia in a middle-aged man. Clin Endocrinol (Oxf) 1993;38:433-437.
3. Farr HW, Fahey TJ Jr, Nash AG, et al. Primary hyperparathyroidism and cancer. Am J Surg 1973;126:539-543.
4. Skrabanek P, McPartlin J, Powell D. Tumor hypercalcemia and "ectopic hyperparathyroidism." Medicine (Baltimore) 1980;59:262-282.
5. Logue FC, Perry B, Chapman RS, et al. A two-site immunoradiometric assay for PTH (1-84) using N and C terminal specific monoclonal antibodies. Ann Clin Biochem 1991;28(pt 2):160-166.
6. Ratcliffe WA, Hutchesson AC, Bundred NJ, et al. Role of assays of parathyroid-hormone-related protein in investigation of hypercalcemia. Lancet 1992;339:164-167.
7. Bergenfelz A, Norden NE, Ahren B. Intraoperative fall in plasma levels of intact parathyroid hormone after removal of one enlarged parathyroid gland in hyperparathyroid patients. Eur J Surg 1991;157: 109-112.
8. Schweitzer DH, Hamdy NA, Frolich M, et al. Malignancy-associated hypercalcemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome. Clin Endocrinol (Oxf) 1994;41:251-256.
9. Audran M, Minebois-Villegas A, Lortholary A, et al. Contribution of parathyroid horomone-related peptide to the evaluation of hypercalcemia. Rev Rhum Engl Ed 1995;62:189-196.
10. Budayr AA, Nissenson RA, Klein RF, et al. Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia. Ann Intern Med 1989;111:807-812.
11. Schilling T, Pecherstorfer M, Blind E, et al. Parathyroid hormone-related protein (PTHrp) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. J Clin Endocrinol Metab 1993;76: 801-803.
12. Endres DB, Villanueva R, Sharp CF Jr, et al. Measurement of parathyroid hormone. Endocrinol Metab Clin North Am 1989;18:611-629.
13. Syed MA, Horwitz MJ, Tedesco MB, et al. Parathyroid hormone-related protein (1-36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy. J Clin Endocrinol Metab 2001;86:1525-1531.